Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications
Abstract
:1. Introduction
2. Human Amniotic Membrane
3. Cell Death/Survival and Differentiation
4. Potential Impact of Cell Viability When hAM Is Used as a Matrix
5. Conclusions
Author Contributions
Funding
Acknowledgments
Conflicts of Interest
References
- Davis, J.S., II. Skin Grafting at the Johns Hopkins Hospital. Ann. Surg. 1909, 50, 542–549. [Google Scholar] [CrossRef] [PubMed]
- Rotth, A. Plastic repair of conjunctival defects with fetal membranes. Arch. Ophthalmol. 1940, 23, 522–525. [Google Scholar] [CrossRef]
- Dino, B.R.; Eufemio, G.; de Villa, M.; Reysio-Cruz, M.; Jurado, R.A. The use of fetal membrane homografts in the local man-agement of burns. J. Philipp. Med. Assoc. 1965, 41, 890–898. [Google Scholar]
- Colocho, G.; Graham, W.P., 3rd; Greene, A.E.; Matheson, D.W.; Lynch, D. Human amniotic membrane as a physiologic wound dressing. Arch. Surg. 1974, 109, 370–373. [Google Scholar] [CrossRef] [PubMed]
- Lai, D.R.; Chen, H.R.; Lin, L.M.; Huang, Y.L.; Tsai, C.C. Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J. Oral. Pathol. Med. 1995, 24, 402–406. [Google Scholar] [CrossRef]
- Ragazzo, M.; Trojan, D.; Spagnol, L.; Paolin, A.; Nardini, L.G. Use of amniotic membrane in the treatment of patients with BRONJ: Two case reports. J. Surg. Case Rep. 2018, 2018, rjy073. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fenelon, M.; Catros, S.; Fricain, J.C. What is the benefit of using amniotic membrane in oral surgery? A comprehensive review of clinical studies. Clin. Oral Investig. 2018, 22, 1881–1891. [Google Scholar] [CrossRef]
- Dua, H.S.; Gomes, J.A.; King, A.J.; Maharajan, V.S. The amniotic membrane in ophthalmology. Surv. Ophthalmol. 2004, 49, 51–77. [Google Scholar] [CrossRef]
- Dino, B.R.; Eufemio, G.; de Villa, M. Human amnion: The establishment of an amnion bank and its practical application in surgery. J. Philipp. Med. Assoc. 1966, 42, 230. [Google Scholar]
- Jirsova, K.; Jones, G.L.A. Amniotic membrane in ophthalmology: Properties, preparation, storage and indications for graft-ing—A review. Cell Tissue Bank 2017, 18, 193–204. [Google Scholar] [CrossRef]
- Odet, S.; Louvrier, A.; Meyer, C.; Nicolás, F.J.; Hofmann, N.; Chatelain, B.; Mauprivez, C.; Laurence, S.; Kerdjoudj, H.; Zwetyenga, N.; et al. Surgical application of human amniotic membrane and amnion-chorion membrane in the oral cavity and efficacy evaluation: Corollary with ophthalmological and wound healing experiences. Front. Bioeng. Biotechnol. 2021, 9, 685128. [Google Scholar] [CrossRef] [PubMed]
- Silini, A.R.; Cargnoni, A.; Magatti, M.; Pianta, S.; Parolini, O. The Long Path of Human Placenta, and Its Derivatives, in Re-generative Medicine. Front. Bioeng. Biotechnol. 2015, 3, 162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Samandari, M.H.; Yaghmaei, M.; Ejlali, M.; Moshref, M.; Saffar, A.S. Use of amnion as a graft material in vestibuloplasty: A preliminary report. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontology 2004, 97, 574–578. [Google Scholar] [CrossRef]
- Akle, C.A.; Adinolfi, M.; Welsh, K.I.; Leibowitz, S.; McColl, I. Immunogenicity of human amniotic epithelial cells after trans-plantation into volunteers. Lancet 1981, 2, 1003–1005. [Google Scholar] [CrossRef]
- Uçakhan, O.O.; Köklü, G.; Firat, E. Nonpreserved human amniotic membrane transplantation in acute and chronic chemical eye injuries. Cornea 2002, 21, 169–172. [Google Scholar] [CrossRef] [PubMed]
- Gabler, B.; Lohmann, C.P. Hypopyon after repeated transplantation of human amniotic membrane onto the corneal surface. Ophthalmology 2000, 107, 1344–1346. [Google Scholar] [CrossRef]
- Mermet, I.; Pottier, N.; Sainthillier, J.M.; Malugani, C.; Cairey-Remonnay, S.; Maddens, S.; Riethmuller, D.; Tiberghien, P.; Humbert, P.; Aubin, F. Use of amniotic membrane transplantation in the treatment of venous leg ulcers. Wound Repair Regen. 2007, 15, 459–464. [Google Scholar] [CrossRef]
- Franck, O.; Descargues, G.; Menguy, E.; Courville, P.; Martin, J.; Brasseur, G.; Muraine, M. Technique of harvesting and preparation of amniotic membranes. J. Fr. Ophtalmol. 2020, 23, 729–734. [Google Scholar]
- Paolin, A.; Cogliati, E.; Trojan, D.; Griffoni, C.; Grassetto, A.; Elbadawy, H.M.; Ponzin, D. Amniotic membranes in ophthal-mology: Long term data on transplantation outcomes. Cell Tissue Bank 2016, 17, 51–58. [Google Scholar] [CrossRef] [Green Version]
- Fenelon, M.; Chassande, O.; Kalisky, J.; Gindraux, F.; Brun, S.; Bareille, R.; Ivanovic, Z.; Fricain, J.C.; Boiziau, C. Human amniotic membrane for guided bone regeneration of calvarial defects in mice. J. Mater. Sci. Mater. Med. 2018, 29, 78. [Google Scholar] [CrossRef]
- Laurent, R.; Nallet, A.; Obert, L.; Nicod, L.; Gindraux, F. Storage and qualification of viable intact human amniotic graft and technology transfer to a tissue bank. Cell Tissue Bank 2014, 15, 267–275. [Google Scholar] [CrossRef] [PubMed]
- Hennerbichler, S.; Reichl, B.; Pleiner, D.; Gabriel, C.; Eibl, J.; Redl, H. The influence of various storage conditions on cell viability in amniotic membrane. Cell Tissue Bank 2007, 8, 1–8. [Google Scholar] [CrossRef] [PubMed]
- Wagner, M.; Walter, P.; Salla, S.; Johnen, S.; Plange, N.; Rütten, S.; Goecke, T.W.; Fuest, M. Cryopreservation of amniotic membrane with and without glycerol additive. Graefes Arch. Clin. Exp. Ophthalmol. 2018, 256, 1117–1126. [Google Scholar] [CrossRef] [PubMed]
- Hettiarachchi, D.; Dissanayake, V.H.; Goonasekera, H.W. Optimizing amniotic membrane tissue banking protocols for oph-thalmic use. Cell Tissue Bank 2016, 17, 387–397. [Google Scholar] [CrossRef]
- Rodrigues, E.B.; Costa, E.F.; Penha, F.M.; Melo, G.B.; Bottos, J.; Dib, E.; Furlani, B.; Lima, V.C.; Maia, M.; Meyer, C.H.; et al. The use of vital dyes in ocular surgery. Surv. Ophthalmol. 2009, 54, 576–617. [Google Scholar] [CrossRef]
- Lindenmair, A.; Wolbank, S.; Stadler, G.; Meinl, A.; Peterbauer-Scherb, A.; Eibl, J.; Polin, H.; Gabriel, C.; van Griensven, M.; Redl, H. Osteogenic differentiation of intact human amniotic membrane. Biomaterials 2010, 31, 8659–8665. [Google Scholar] [CrossRef]
- Gualdi, T.; Laurent, R.; Moutarlier, V.; Fenelon, M.; Nallet, A.; Pouthier, F.; Obert, L.; de Billy, B.; Meyer, C.; Gindraux, F. In vitro osteodifferentiation of intact human amniotic membrane is not beneficial in the context of bone repair. Cell Tissue Bank 2019, 20, 435–446. [Google Scholar] [CrossRef]
- Centurione, L.; Passaretta, F.; Centurione, M.A.; Munari, S.; Vertua, E.; Silini, A.; Liberati, M.; Parolini, O.; di Pietro, R. Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity. Cell Transpl. 2018, 27, 12–22. [Google Scholar] [CrossRef]
- Laurent, R.; Nallet, A.; de Billy, B.; Obert, L.; Nicod, L.; Meyer, C.; Layrolle, P.; Zwetyenga, N.; Gindraux, F. Fresh and in vitro osteodifferentiated human amniotic membrane, alone or associated with an additional scaffold, does not induce ectopic bone formation in Balb/c mice. Cell Tissue Bank 2017, 18, 17–25. [Google Scholar] [CrossRef]
- Fenelon, M.; Maurel, D.B.; Siadous, R.; Gremare, A.; Delmond, S.; Durand, M.; Brun, S.; Catros, S.; Gindraux, F.; L’Heureux, N.; et al. Comparison of the impact of preservation methods on amniotic membrane properties for tissue engineering applications. Mater. Sci. Eng. C Mater. Biol. Appl. 2019, 104, 109903. [Google Scholar] [CrossRef]
- Fenelon, M.; Etchebarne, M.; Siadous, R.; Gremare, A.; Durand, M.; Sentilhes, L.; Torres, Y.; Catros, S.; Gindraux, F.; L’Heureux, N.; et al. Assessment of fresh and preserved amniotic membrane for guided bone regeneration in mice. J. Biomed. Mater. Res. A 2020, 108, 2044–2056. [Google Scholar] [CrossRef] [PubMed]
- Fénelon, M.; Etchebarnea, M.; Siadous, R.; Grémare, A.; Durand, M.; Sentilhes, L.; Catros, S.; Gindraux, F.; L’Heureux, N.; Fricain, J.C. Comparison of amniotic membrane versus the induced membrane for bone regeneration in long bone segmental defects using calcium phosphate cement loaded with BMP-2. Mater. Sci. Eng. C Mater. Biol. Appl. 2021, 124, 112032. [Google Scholar] [CrossRef] [PubMed]
- Gindraux, F.; Rondot, T.; de Billy, B.; Zwetyenga, N.; Fricain, J.C.; Pagnon, A.; Obert, L. Similarities between induced membrane and amniotic membrane: Novelty for bone repair. Placenta 2017, 59, 116–123. [Google Scholar] [CrossRef] [PubMed]
- Banerjee, A.; Weidinger, A.; Hofer, M.; Steinborn, R.; Lindenmair, A.; Hennerbichler-Lugscheider, S.; Eibl, J.; Redl, H.; Kozlov, A.V.; Wolbank, S. Different metabolic activity in placental and reflected regions of the human amniotic membrane. Placenta 2015, 36, 1329–1332. [Google Scholar] [CrossRef]
- Weidinger, A.; Pozenel, L.; Wolbank, S.; Banerjee, A. Sub-Regional Differences of the Human Amniotic Membrane and Their Potential Impact on Tissue Regeneration Application. Front. Bioeng. Biotechnol. 2020, 8, 613804. [Google Scholar] [CrossRef]
- Gremare, A.; Jean-Gilles, S.; Musqui, P.; Magnan, L.; Torres, Y.; Fenelon, M.; Brun, S.; Fricain, J.C.; L’Heureux, N. Cartography of the mechanical properties of the human amniotic membrane. J. Mech. Behav. Biomed. Mater. 2019, 99, 18–26. [Google Scholar] [CrossRef]
- Niknejad, H.; Peirovi, H.; Jorjani, M.; Ahmadiani, A.; Ghanavi, J.; Seifalian, A.M. Properties of the amniotic membrane for potential use in tissue engineering. Eur. Cells Mater. 2008, 15, 88–99. [Google Scholar] [CrossRef]
- Leal-Marin, S.; Kern, T.; Hofmann, N.; Pogozhykh, O.; Framme, C.; Borgel, M.; Figueiredo, C.; Glasmacher, B.; Gryshkov, O. Human Amniotic Membrane: A review on tissue engineering, application, and storage. J. Biomed. Mater. Res. B Appl. Biomater. 2020, 109, 1198–1215. [Google Scholar] [CrossRef]
- Thomasen, H.; Pauklin, M.; Steuhl, K.P.; Meller, D. Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications. Graefes Arch. Clin. Exp. Ophthalmol. 2009, 247, 1691–1700. [Google Scholar] [CrossRef]
- Singh, R.; Chacharkar, M.P. Dried gamma-irradiated amniotic membrane as dressing in burn wound care. J. Tissue Viability 2011, 20, 49–54. [Google Scholar] [CrossRef]
- Pogozhykh, O.; Hofmann, N.; Gryshkov, O.; von Kaisenberg, C.; Mueller, M.; Glasmacher, B.; Pogozhykh, D.; Borgel, M.; Blasczyk, R.; Figueiredo, C. Repeated Freezing Procedures Preserve Structural and Functional Properties of Amniotic Mem-brane for Application in Ophthalmology. Int. J. Mol. Sci. 2020, 21, 4029. [Google Scholar] [CrossRef]
- Lamon, M.; Bertolin, M.; Trojan, D.; Spagnol, L.; Donisi, P.M.; Camposampiero, D.; Ponzin, D.; Ferrari, S. Cryopreservation of human amniotic membrane for ocular surface reconstruction: A comparison between protocols. Cell Tissue Bank 2022. [Google Scholar] [CrossRef] [PubMed]
- Ragazzo, M.; Val, M.; Montagner, G.; Trojan, D.; Fusetti, S.; Nardini, L.G. Human amniotic membrane: An improvement in the treatment of Medication-related osteonecrosis of the jaw (MRONJ)? A case-control study. Cell Tissue Bank 2022, 23, 129–141. [Google Scholar] [CrossRef] [PubMed]
- Odet, S.; Meyer, C.; Gaudet, C.; Weber, E.; Quenot, J.; Derruau, S.; Laurence, S.; Bompy, L.; Girodon, M.; Chatelain, B.; et al. Tips and Tricks and Clinical Outcome of Cryopreserved Human Amniotic Membrane Application for the Management of Medi-cation-Related Osteonecrosis of the Jaw (MRONJ): A Pilot Study. Front. Bioeng. Biotechnol. 2022, 10, 936074. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Gaudet, C.; Solecki, L.; Mathéaud, B.; Odet, S.; Meyer, C.; Louvrier, A.; Gindraux, F. Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications. Biomedicines 2022, 10, 2456. https://doi.org/10.3390/biomedicines10102456
Gaudet C, Solecki L, Mathéaud B, Odet S, Meyer C, Louvrier A, Gindraux F. Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications. Biomedicines. 2022; 10(10):2456. https://doi.org/10.3390/biomedicines10102456
Chicago/Turabian StyleGaudet, Camille, Lauriana Solecki, Bastien Mathéaud, Stephane Odet, Christophe Meyer, Aurélien Louvrier, and Florelle Gindraux. 2022. "Questions about Residual Cell Viability in Cryopreserved Human Amniotic Membrane and Its Impact on Clinical Applications" Biomedicines 10, no. 10: 2456. https://doi.org/10.3390/biomedicines10102456